Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the joint business update call for Gilead Sciences and Galapagos. My name is Daniel, and I'll be your conference operator today. (Operator Instructions) And as a reminder, this conference call is being recorded.
I would now like to turn the call over to Sung Lee, Senior Vice President of Investor Relations. Please go ahead.
Thank you, Daniel. We appreciate everyone joining us on a Sunday for this call.
Earlier today, Gilead and Galapagos issued a press release announcing that both companies have entered into a comprehensive 10-year global clinical and research collaboration. On our call today, we would like to review the terms of the collaboration and benefits to both companies and then address any questions you may have. We have posted a set of slides on each company's website for your reference.
The speakers on today's call will be Daniel O'Day, Chairman and Chief Executive Officer of Gilead Sciences; Onno van de Stolpe,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
